About us
About us
Our Company & Values
Our History
Executive leadership
Our Production department
Our CSR Commitments
We Are Worldwide
Our Latest Investments
Compliance
Our Biopolymers
Innovation & R&D
News
Career
Contact
Eng
Fra
CN
KR
Articles
February 15, 2024
90 years of Hyaluronic Acid with HTL Biotechnology
Celebrations of Hyaluronic Acid are in order in 2024.
Let us explain !
Read the article
Close and continue
Home
-
Sitemap
Sitemap
Explore
Pages
About us
Compliance
Executive leadership
Our Company & Values
Our History
Our Latest Investments
Our Production department
Our CSR Commitments
Career
Nos Métiers
Prepare your Interview
Contact
Cookies Policy
Home
Innovation & R&D
Start-up funding
Legal Notice & GTC
Our Biopolymers
Our R&D Laboratories & Facilities
Biotech Laboratory
Chemistry Laboratory
Privacy Policy
Services
Academic Partnership & Patents
Functionalized Biopolymers Services
Sitemap
Terms & Conditions of Sale
Tomorrow’s applications
We Are Worldwide
Posts by category
Category:
Non classé
News
HTL Biotechnology at CPHI Milano
1st symposium for HTL Biotechnology at MAIS congress
HTL Biotechnology will launch its White Paper at CPHI Milan!
New Certification for HTL Biotechnology
HTL Biotechnology Secures Medical Device Registration in China
HTL Biotechnology at CPHI China 2024
Discover our Quality Policy
National Bioproduction and Biomedicine Day (TVR report)
New Ecovadis Gold label 2024
BIOPHTA 6.5 million Euros Seed Funding
Acquisition of the Modern Meadow’s human recombinant collagen platform for beauty and biomedical applications
HTL Biotechnology at In-cosmetics Global Congress in Paris
France BioLead Membership
Attending AMWC in Monaco
HTL Biotechnology at PCHI
Podcast : Discussion with François Fournier
Our booth at China International Beauty Expo
HTL Biotechnology spotlight at Dubai Derma
90 years of Hyaluronic Acid with HTL Biotechnology
Happy Lunar New Year 2024 !
HTL Biotechnology at IMCAS world congress 2024
HTL Biotechnology will be at IMCAS 2024 !
Happy New Year from the HTL Biotechnology team !
HTL at CPHI 2023 Barcelona
Our new CSR strategy
HTL at CPHI Japan 2023
SFB & TERMIS Americas
HTL team in Korea and China
HTL participation at IMCAS
François Fournier as new CEO
GelMEDIX investment
Montagu as new investor
HTL launches a new bioproduction unit HTL4
BMG Pharma and HTL sign a development agreement
Eirion Therapeutics Announces Strategic Agreement
Terasaki Institute Memorandum of Uderstanding
HTL Biotechnology & Echelon Biosciences strategic partnership
Products
Hyaluronic Acid (Sodium Hyaluronate)
Polynucleotides (PDRN - PN)
Sodium DNA
Heparosan
Oligo HA
News types
Articles
Press releases
Product categories
Innovation Portfolio
Product Portfolio